공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

요통 및 좌골신경통 : 주요 9개 시장 예측

Epiomic Epidemiology Series: Lower Back Pain and Sciatica Forecast in 9 Major Markets 2016-2026

리서치사 Black Swan Analysis
발행일 2016년 10월 상품 코드 374075
페이지 정보 영문 46 Pages
가격
US $ 4,250 ₩ 4,752,000 PDF (Single User License)
US $ 6,400 ₩ 7,156,000 PDF (Site License/Up to 5 Users)
US $ 7,700 ₩ 8,610,000 PDF (Corporate License)


요통 및 좌골신경통 : 주요 9개 시장 예측 Epiomic Epidemiology Series: Lower Back Pain and Sciatica Forecast in 9 Major Markets 2016-2026
발행일 : 2016년 10월 페이지 정보 : 영문 46 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

주요 9개 시장(미국, 프랑스, 독일, 이탈리아, 스페인, 영국, 브라질, 일본, 멕시코)에서 요통 및 좌골신경통(Lower Back Pain & Sciatica)의 현재 환자수(성별, 연령 그룹별)에 대해 조사 분석했으며, 현재 유병률, 질환 개요, 위험인자, 질환 진단과 예후, 주요 증상과 합병증 등의 정보를 전해드립니다.

1. 도표

2. 서론

3. 병인

4. 위험인자와 예방

5. 질환 진단

6. 좌골신경통

7. 변이 : 지역/민족별

8. 질환 예후와 임상 경과

9. 질환과 관련된 주요 합병증/특징

10. 환자수의 정량화 방법

11. 요통의 최대 유병자수

12. 요통 환자의 특징

  • 요통의 원인

13. 요통의 동반질환

14. 좌골신경통의 최대 유병자수

15. 좌골신경통 환자의 특징

16. 약어

17. 관련 발행물

18. 환자 기반 온라인 데이터베이스

19. 환자 기반 제품

20. 온라인 가격 데이터 및 플랫폼

21. 참고문헌

22. 부록

KSM 16.11.02

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Lower Back Pain and Sciatica in 9 Major Markets

Low back pain (LBP) is defined as experiencing musculoskeletal pain, muscle tension, or stiffness localized below the bottom edge of the rib cage and above the gluteal sulcus, with or without sciatica, and is defined as chronic when it persists for 12 weeks or more. This pain may be caused by a variety of diseases and disorders that affect the lumbar spine region.

This report provides the current prevalent population for Lower Back Pain across 9 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil, Japan and Mexico) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of Lower Back Pain have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Key co-morbidities for LBP include:

  • Smoking
  • Obesity & overweight
  • Arthritis
  • Neuropathic components.

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy

  • Able to quantify patient populations in global Lower Back Pain market to target the development of future products, pricing strategies and launch plans.
  • Gain further insight into the prevalence of the subdivided types of Lower Back Pain and identify patient segments with high potential.
  • Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
  • Provide a level of understanding on the impact from specific co-morbid conditions on Lower Back Pain's prevalent population.
  • Identify sub-populations within Lower Back Pain which require treatment.
  • Gain an understanding of the specific markets that have the largest number of Lower Back Pain patients.

Table of Contents

  • List of Tables and Figures
  • Introduction
  • Cause of the Disease
  • Risk Factors & Prevention
  • Diagnosis of the Disease
  • Sciatica
  • Variation by Geography/Ethnicity
  • Disease Prognosis & Clinical Course
  • Key comorbid conditions/Features associated with the disease
  • Methodology for quantification of patient numbers
  • Top-line prevalence for Lower Back Pain
  • Features of Lower Back Pain Patients
    • Cause of the Lower Back Pain
  • Co-morbid conditions in Lower Back Pain
  • Top Line prevalence for Sciatica
  • Features of Sciatica Patients
    • Sciatica Episodes
    • Co-morbid conditions in Sciatica
  • Abbreviations used in the report
  • Other Black Swan Analysis Publications
  • Black Swan Analysis Online Patient-Based Databases
  • Patient-Based Offering
  • Online Pricing Data and Platforms
  • References
  • Appendix

List of Tables

  • Prevalence of Lower Back Pain, total (000s)
  • Prevalence of Lower Back Pain, males (000s)
  • Prevalence of Lower Back Pain, females (000s)
  • Cause of the Lower Back Pain, total (000s)
  • Dysthymia in patients with Lower Back Pain, total (000s)
  • Migraine in patients with Lower Back Pain, total (000s)
  • Neuropathic Component in patients with Lower Back Pain, total (000s)
  • PTSD in patients with Lower Back Pain, total (000s)
  • Smoking in patients with Lower Back Pain, total (000s)
  • Obesity in patients with Lower Back Pain, total (000s)
  • Generalized Anxiety Disorder (GAD) in patients with Lower Back Pain, total (000s)
  • Arthritis in patients with Lower Back Pain, total (000s)
  • Agoraphobia in patients with Lower Back Pain, total (000s)
  • Prevalence of Sciatica, total (000s)
  • Prevalence of Sciatica, males (000s)
  • Prevalence of Sciatica, females (000s)
  • Duration of current Sciatica episode, total (000s)
  • Levels of Leg Pain Bothersomeness for Sciatica patients, total (000s)
  • Sciatica patients with herniated disc, total (000s)
  • Sciatica patients that are current smokers, total (000s)
  • Sciatica patients with muscular paresis, total (000s)
  • Sciatica patients with muscular impairment, total (000s)
  • Sciatica patients with depressed reflexes, total (000s)
  • Positive straight leg raising test in patients with Sciatica, total (000s)
  • Abbreviations and Acronyms used in the report
  • USA Prevalence of Lower Back Pain by 5-yr age cohort, males (000s)
  • USA Prevalence of Lower Back Pain by 5-yr age cohort, females (000s)
  • France Prevalence of Lower Back Pain by 5-yr age cohort, males (000s)
  • France Prevalence of Lower Back Pain by 5-yr age cohort, females (000s)
  • Germany Prevalence of Lower Back Pain by 5-yr age cohort, males (000s)
  • Germany Prevalence of Lower Back Pain by 5-yr age cohort, females (000s)
  • Italy Prevalence of Lower Back Pain by 5-yr age cohort, males (000s)
  • Italy Prevalence of Lower Back Pain by 5-yr age cohort, females (000s)
  • Spain Prevalence of Lower Back Pain by 5-yr age cohort, males (000s)
  • Spain Prevalence of Lower Back Pain by 5-yr age cohort, females (000s)
  • UK Prevalence of Lower Back Pain by 5-yr age cohort, males (000s)
  • UK Prevalence of Lower Back Pain by 5-yr age cohort, females (000s)
  • Brazil Prevalence of Lower Back Pain by 5-yr age cohort, males (000s)
  • Brazil Prevalence of Lower Back Pain by 5-yr age cohort, females (000s)
  • Japan Prevalence of Lower Back Pain by 5-yr age cohort, males (000s)
  • Japan Prevalence of Lower Back Pain by 5-yr age cohort, females (000s)
  • Mexico Prevalence of Lower Back Pain by 5-yr age cohort, males (000s)
  • Mexico Prevalence of Lower Back Pain by 5-yr age cohort, females (000s)
Back to Top
전화 문의
F A Q